INSTRUCTIONS TO AUTHORS

 



ONLINE MANUSCRIPT SUBMISSION: An online submission and tracking service via Internet facilitates a speedy and cost-effective submission of manuscripts. The full manuscript has to be submitted online.


Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Covering Letter along with the manuscript, on behalf of all the co-authors (if any). The author(s) will confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained.


For all online submissions, please provide soft copies of all the materials (main text in MS Word or Tex/LaTeX), figures / illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures / illustrations / tables / chemical structures etc.


It is imperative that before submission, authors should carefully proofread the files for special characters, mathematical symbols, Greek letters, equations, tables, references and images, to ensure that they appear in proper format.


References, figures, tables, chemical structures, etc. should be referred to in the text at the place where they have been first discussed. Figure legends/ caption should also be provided.


A successful electronic submission of a manuscript will be followed by a system-generated acknowledgement to the principal/corresponding author. Any queries therein should be addressed to shhaward@emirates.net.ae


If accepted, Sheikh Hamdan Award for Medical Sciences have the exclusive license to publish the paper.


MANUSCRIPT PUBLISHED: The journal publishes peer reviewed letters, research articles, review articles and thematic issues written in English.


Single Topic Issues: These special issues are peer reviewed and may either contain invited review articles or a mixture of research, letter and review articles. A Single Topic Special Editor will offer a short Perspective and coordinate the solicitation of manuscripts between 3-5 (for a mini-hot topic) to 6-10 (for full- length hot topic) from leading scientists. Authors interested in editing a single topic issue in an emerging topic of medical sciences may submit their proposal to the Editor-in-Chief at (email to be provided) for consideration.


MANUSCRIPT LENGTH:


Letters: The maximum total page length for Letter type articles published in the journal is one journal page. Each journal page is on average 900 words.


Research Articles: The maximum total page length for Research articles is eight journal pages. Each journal page is on average 900 words.


Review Articles: The maximum total page length for Review articles is four journal pages. Each journal page is on average 900 words.


Authors should include all relevant supporting data with each article.


MANUSCRIPT PREPARATION: The manuscript should be written in English in a clear, direct and active style. All pages must be numbered sequentially, facilitating in the reviewing and editing of the manuscript.


MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts should be divided into the following sections.


Covering letter
Title
Title Page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices (if any)
Figures/illustrations (if any)
Chemical structures (if any)
Tables (if any)
Supportive/ supplementary material (if any)


Covering Letter: It is a mandatory requirement that a signed covering letter also be submitted along with the manuscript by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. All inconsistencies in the text and in the reference section, and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article contains no such material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. The authors acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copy right agreement. Covering letter can be downloaded from the journal’s Web site. (Website address)


Title: The title of the article should be precise and brief and must not be more than 120 characters. Authors should avoid the use of non-standard abbreviations. The title must be written in title case except for articles, conjunctions and prepositions.


Authors should also provide a short ‘running title’. Title, running title, byline, correspondent, footnote and keywords should be written as presented in original manuscripts.


Title Page:
Example of a title page showing content and spacing. A space of 7-8 cm should be left at the top of the page.


Consanguineous marriages in Arabs (title)
LI Al Gazali, B Ali (authors)
Department of Paediatrics, UAE University, Al Ain, United Arab Emirates
Short title: Consanguineous marriages
Corresponding author: LI Al Gazali, Department of Pediatrics, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, United Arab Emirates Tel: +97137137332, Fax: +97137672022.


Abstract: The abstract of a research and review article should not exceed 250 words and 150 words for letter articles, should be structured with the following headings: Aim, Methods, Results and Conclusion. Where appropriate, use Design, Setting, Subjects, Interventions and Main outcome measures.


Keywords: Provide maximum 5 key words in alphabetical order.


Text Organization:
The main text should begin on a separate page and should be divided into separate sections. A left-hand margin of about 4 cm should be left. The pages numbers should be given in the top right-hand corner, beginning with the title page. For Letter/Research Articles, the manuscript should begin with the title page and abstract followed by the main text, which must be structured into separate sections as Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgements and References. The text may be subdivided further according to the areas to be discussed, which should be followed by the Acknowledgement (if any) and Reference sections. A Review Article should begin with general overview of the topic and mention any important previous reviews. It should then proceed to discuss the salient features of recent developments. The authors should avoid presenting material which has already been published in a previous review.


The authors are advised to present and discuss their observations in brief. The manuscript style must be uniform throughout the text and 10 pt Times New Roman fonts should be used. The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. The reference numbers should be given in square brackets in the text. Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. in vivo, in vitro, per se, et al. etc.


• Presentation: Manuscripts should be double-spaced throughout and with adequate margins. Footnotes to the text should be avoided. Quotation marks should be single, and not double. Italics, as in the case of genotypes or algebraic parameters in the text, should be indicated either by italic type or by underlining. This is however, not necessary in numbered equations where mathematical symbols will be italicized as a matter of course. The carriage return (enter) at the end of lines within a paragraph should not be used. The authors are advised to maintain consistency. Same presentation should be used for all headings, etc. that are to appear the same in the finished printing.


Layout:
The authors must follow these simple guidelines when preparing the electronic manuscript.


(i) Key elements should be consistent throughout. (ii) The words should not be broken at the ends of lines. A hyphen should be used only to hyphenate compound words. (iii) Single space only to be used at the ends of sentences. (iv) Underline to be avoided; Italics feature to be used instead. (v) Right-hand margin should be unjustified. (vi) A double hyphen should be used to indicate a dash. (vii) Avoid usage of the lower case "ell" for 1 (one) or the upper case O for 0 (zero). (viii) When indenting paragraphs or separating columns in tables, the TAB key instead of the spacebar should be used.


The entire manuscript should be double-spaced. The manuscript should be prepared with each of the following parts starting on a new page: (1) The title, with authors' names and affiliations (as a rule the number of authors should be limited to six. The names of others who contributed to the article in varying degree should be mentioned under the heading "Acknowledgements"), the address of the corresponding author and a short running title; (2) the abstract ending with one or two sentences of conclusion, summarizing the message of the article including keywords; (3) the text; (4) the references; (5) tables; (6) figure legends.


Trial Registration. In case the research article reports the results of a controlled health care intervention, trial registry should be listed, along with the unique identifying number, e.g. Trial registration: Current Controlled Trials ISRCTN73824458. Note that there should be no space between the letters and numbers of your trial registration number. For this purpose, a clinical trial is any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause-and-effect relationship between a medical intervention and a health outcome. All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempt. Trial registry name, registration identification number, and the URL for the registry should be included at the end of abstract and also in the space provided on the online manuscript submission form. If the research article reports the results of a controlled health care intervention, trial registry should be listed, along with the unique identifying number. Note that there should be no space between the letters and numbers of your trial registration number.


CONSORT Statement:
Authors will submit the Trial Protocols along with their manuscript. The CONSORT (Consolidated Standards of Reporting Trials) Checklist and Flowchart is also required when submitting the results of randomized control trials (RCTs).


Ethical Approval of Studies and Informed Consent: When reporting experiments on human subjects, the authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. Patients' names, initials, or hospital numbers should not be used, especially in illustrative material. Papers including animal experiments or clinical trials must be approved by the institutional ethics committee.


For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee and should be documented in the paper. For investigations undertaken on human subjects, state in the Methods section the manner in which the informed consent was obtained from the study participants (i.e., oral or written), where there is an unavoidable risk of breach of privacy e.g., in a clinical photograph or in case details the patient’s written consent or that of the next of kin, to publication must be obtained. The authors will have to send a signed consent form before publication. Consent must be obtained for all Case Reports and Clinical Pictures.


Greek Symbols and Special Characters: Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of manuscript for publication. To ensure that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format styling (Symbol font face) otherwise they will be lost during conversion to PDF/XML.


Units of Scientific Measurement and Nomenclature:
Authors are encouraged to consult reporting guidelines. These guidelines provide a set of recommendations comprising a list of items relevant to their specific research design. All kinds of measurements should be reported only in International System of Units (SI). Chemical equations, chemical names, mathematical usage, unit of measurements, chemical and physical quantity & units must conform to SI and Chemical Abstracts or IUPAC. Wherever drugs are referred to, it is preferable to use generic (non-proprietary) rather than trade names. Numbers less than 10 should be spelled out in words; numbers greater than 10 may be written in Arabic numerals.


Notes/ Footnotes:
Notes/footnotes in the text are to be incorporated, within parentheses, rather than in their usual place at the foot of the page.


Statistic Validity:
If statistical data are provided the authors may be requested to submit an official statement issued by a certified statistician (with a proper affiliation) regarding the validity of the methods used.


List of Abbreviations: If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided. Abbreviations should be used in the title or Abstract, and in the text only standard abbreviations should be used, i.e. those listed in the latest editions of any recognized medical dictionary (e.g. Dorland's, Butterworth's). The full term for which an abbreviation stands should precede its first use in the text, unless it is a standard unit of measurement. Redefine abbreviations used in the figure legends.


Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.


Acknowledgements: Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section.


Protection of Human Subjects and Animals in Research:
When reporting experiments involving human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.


For research involving animals, authors should indicate whether the procedures followed were in accordance with the standards set forth in the Guide for the Care and Use of Laboratory Animals (published by the National Academy of Science, National Academy Press, Washington, D.C.).


References: References must be listed in the numerical system (Vancouver). Number the references consecutively in the order in which they are first mentioned in the text. Identify references in the text, tables and legends by Arabic numerals (in superscript). Type list of references as illustrated. The reference numbers must be finalized and the bibliography must be fully formatted before submission.


See below few examples of references listed in the correct Vancouver style:


Typical Paper Reference:
1. Sudo T, Hiyama E, Murakami Y, Yokoyama Y, Takesue Y, Sueda T. Hepatic regeneration promotes engraftment of intraportally transplanted islet cells. Surgery 2005; 137: 612-9.
2. Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, et al. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 1997; 46: 28-33.


Typical Chapter Reference:
3. Stevenson WG, Friedman PL. In: Hennekens CH, Ed. Clinical trials in cardiovascular disease. Philadelphia, WB Saunders Co. 1999; 217-30.


Book Reference:
4. Carlson BM. Human embryology and developmental biology. 3rd ed. St. Louis: Mosby 2004.


Edited Book:
5. Brown AM, Stubbs DW, Eds. Medical physiology. New York: Wiley 1983.


Conference Proceedings:
6. Anderson JC. Current status of chorion villus biopsy. In: Tudenhope D, Chenoweth J, Eds. Proceedings of the 4th Congress of the Australian Perinatal Society; 1986: Brisbane, Queensland: Australian Perinatal Society 1987; pp. 190-6.


Journal Article on the Internet:
7. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1): [24 screens]. Available from:

Book/Monograph on the Internet:
8. Donaldson MS, Ed. Measuring the quality of health care [monograph on the internet]. Washington: National Academy Press; 1999 [cited 2004 Oct 8]. Available
9. HeartCentreOnline [homepage on the Internet]. Boca Raton, FL: HeartCentreOnline, Inc.; c2000-2004 [updated 2004 May 23; cited 2004 Oct 15]. Available


Issue with Supplement:
10. Glauser TA. Integrating clinical trial data into clinical practice. Neurology 2002; 58(12 Suppl 7): S6-12.

 

Volume with Part:
11. Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal 2002; 83(Pt 2): 491-5.


Issue with Part:
12. Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol 2002; 13(9 Pt 1): 923- 8.


Patent:
13. Pagedas AC. Flexible endoscopic grasping and cutting device and positioning tool assembly. US 20020103498. 2002 Aug.


Some important points to remember:


* All references must be complete and accurate.
* If the number of authors exceeds six then et al. will be used after six names (the term “et al.” should be in italics).
* Online citations should include the date of access.
* Journal abbreviations should follow the Index Medicus/MEDLINE.
* Take special care of the punctuation convention as described in the above-mentioned examples.
* Avoid using superscript in the in-text citations and reference section.
* Abstracts, unpublished data and personal communications (which can only be included if prior permission has been obtained) should not be given in the reference section but they may be mentioned in the text and details provided as footnotes.
* The authors are encouraged to use a recent version of EndNote (version 5 and above) or Reference Manager (version 10) when formatting their reference list, as this allows references to be automatically extracted.
* References to papers accepted but not yet published should be designated as "in press"; authors should provide verification that they have been accepted for publication. Information from manuscripts submitted but not accepted should be cited in the text as " unpublished observations" with written permission from the source.
* Citing a "personal communication" should be avoided unless it provides essential information not available from a public source, in such a case, the name of the person and date of communication should be cited in parentheses in the text.


Appendices:
In case there is a need to present lengthy, but essential methodological details, use appendixes, which can be a part of the article. An appendix must not exceed three pages (Times New Roman, 12 point fonts, 900 max. words per page).The information should be provided in a condensed form, ruling out the need of full sentences. A single appendix should be titled APPENDIX, while more than one can be titled APPENDIX A, APPENDIX B, and so on.


Figures/ Illustrations:
Should your manuscript be accepted, the authors may be asked to supply glossy prints rather than original illustrations in such cases the authors should identify them on the back by name and number. They must be camera-ready with an allowance of 25-50% for reduction in print. If necessary, the top of the figure on the reverse must be indicated lightly. Photographs should be unmounted. In manuscripts that contain photographs of patients, the publishers require a certificate by the author that consent to publish such a photograph has been given by the patient, a child's parent or a caretaker.


Grey-shaded areas on computer-drawn figures (tinting) should be avoided.


Preferably, figures should require no alteration in scale; in particular the authors should note that various levels of stippling and cross-hatching are often indistinguishable when the size is reduced.


To produce electronic artwork of suitable quality for printing, appropriate software should be used, e.g. Adobe Illustrator, Adobe Photoshop, Canvas or Freehand. Microsoft Office applications e.g. Word, Excel or PowerPoint should not be used as these applications are unable to produce electronic artwork of the required quality.


Legends to figures should be given, double-spaced, as continuous text, on a separate page in the main text file.


Color Figures Publication:
* Color figures should be supplied in CMYK not RGB colors.


Electronic Artwork:
The artwork must be supplied in electronic form.


Vector graphics must be saved (e.g. line artwork) in Encapsulated Postscript Format (EPS), and bitmap files (e.g. half-tones) in Tagged Image File Format (TIFF). Half-tones should always be supplied as hard copy as well as electronically.


TIFF files should be supplied in the following resolutions: 600 d.p.i. (dots per inch) for line art; 600 d.p.i. for half-tones that contain lettering; and 300 d.p.i. for half-tones containing no lettering.


Tables:
* Data Tables should be submitted in Microsoft Word table format.
* Each table should include a title/caption being explanatory in itself with respect to the details discussed in the table. Detailed legends may then follow.
* Table number i.e. Table 1, should follow a title. The title should be in small case with the first letter in caps. A full stop should be placed at the end of the title.
* Tables should be embedded in the text exactly according to their appropriate placement in the submitted manuscript.
* Columns and rows of data should be made visibly distinct by ensuring that the borders of each cell are displayed as black lines.
* Tables should be numbered in Arabic numerals sequentially in order of their citation in the body of the text.
* If a reference is cited in both the table and text, a lettered footnote should be inserted in the table to refer to the numbered reference in the text.
* Tabular data provided as additional files can be submitted as an Excel spreadsheet.


Supporting/ Supplementary Information:
Supporting Information, such as data sets or additional figures or tables, that will not be published in the print edition of the journal, but which will be viewable via the online edition, can be submitted.


It should be clearly stated at the time of submission that the authors intend for the Supporting Information to be made available through the online edition. Supporting Information will be made available in the electronic form free of charge either through the journal's Web pages or on request from HMJ. Alternatively, if the size or format of the Supporting Information is such that it cannot be accommodated on the journal's Web site, the author may choose to make the Supporting Information available free of charge on a permanent Web site, to which links will be set up from Journal of Medical Sciences' Web site. The author must advise HMJ if the URL of the Web site where the Supporting Information is located, changes.


The availability of Supporting Information should be indicated in the main manuscript by a paragraph, to appear after the References, headed 'Supporting Information' and providing titles of figures, tables, etc. The Supporting Information should be submitted to the Editorial Office in final form, ready for viewing, or alternatively, if the size or format is such that it cannot be submitted, the author should make the Supporting Information available for viewing in final form via the Web by the Editorial Office and by reviewers. No changes can be made subsequently by the Editorial Office or the Publisher. This Supporting Information is an integral part of the article and will be reviewed accordingly.


PERMISSION FOR REPRODUCTION: Published/reproduced material should not be included without written permission from the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of the article for publication.


For obtaining permission for reproducing any material published in a paper by HMJ Science Publishers, the request FORM needs to be filled in and sent to (email address) for consideration.


AUTHORS AND INSTITUTIONAL AFFILIATIONS: The author will be required to provide their full names, the institutional affiliations and the location, with an asterisk in front of the name of the principal/corresponding author. The corresponding author(s) should be designated and their complete address, business telephone and fax numbers and e-mail address must be stated to receive correspondence and galley proofs.


LANGUAGE AND EDITING: Manuscripts must be written in good English in a clear and correct style. In order to maintain uniformity throughout the text, the manuscript should be written in either American or British English. Submitted manuscripts will not be edited for style or language, and reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Non-native speakers of English may choose to make use of a copyediting and language editing service such as that provided by Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences (please contact at email: email address).


All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.


PROOF CORRECTIONS: Authors are required to proofread the PDF versions of their manuscripts before submission. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Major changes are not acceptable at the proof stage. If unable to send corrections within 48 hours due to some reason, the author(s) must at least send an acknowledgement on receiving the galley proofs or the article will be published exactly as received and the publishers will not be responsible for any error occurring in the manuscript in this regard.


The corresponding author will be solely responsible for ensuring that the revised version of the manuscript incorporating all the submitted corrections receives the approval of all the authors of the manuscript.


Proofs will be posted if no email address is available; in the authors’ absence, a colleague must be held responsible to access your email to retrieve the proofs.


OFFPRINTS: High quality printed offprints of published articles are available for purchase, if ordered, with a minimum number of 100 offprint.


HMJ:
HMJ is a pay-to-publish service from HMJ that allows open access publication of print version of the accepted articles (i.e. free for all to view and download). The open access publication fees are met by Sheikh Hamdan Award for Medical Sciences on behalf of the Author in advance of publication. Upon online publication, the article (both full-text and PDF versions) will be available to all for viewing and download absolutely free of charge.


REVIEWING AND PROMPTNESS OF PUBLICATION: All manuscripts submitted for publication will be immediately subjected to peer-reviewing, usually in consultation with the members of the Editorial Advisory Board and a number of external referees. Authors may, however, provide the contact details (including e-mail addresses) of four potential peer reviewers for their paper. Recommended peer reviewers should not have collaborated with any of the authors within the previous five years or be former students, advisors or members of the same research institution.


All peer-reviewing will be conducted via the Internet to facilitate rapid reviewing of the submitted manuscripts. Every possible effort will be made to assess the manuscripts at the earliest with the decision being conveyed to the authors in due course.


COPYRIGHT ASSIGNMENT/EXCLUSIVE LICENSE:
Authors are no longer required to assign copyright in their paper. Instead authors are required to assign the exclusive license to publish their paper to HMJ and the Journal of Medical Sciences. Assignment of the exclusive license is a condition of publication and papers will not be passed to the publisher for production unless license has been assigned. Please download the Exclusive License Form () and ensure this is returned to the Production Editor. It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.


E-PUB AHEAD OF SCHEDULE: HMJ Science Publishers are pleased to offer electronic publication of accepted papers prior to scheduled publication. These peerreviewed papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue. Articles ahead of schedule may be ordered by payper- view at the relevant links by each article stated via the E-Pub Ahead of Schedule (http://www.HMJscience.com/jms/E-Pub- Ahead-of-Schedule.htm).


Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule sections have been peer-reviewed and accepted for publication in this journal and posted online before scheduled publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, HMJ Science Publishers, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained of articles in the E-Pub Ahead-of-Schedule.



Search

SELECTED POSTS

Neonatal Sepsis In The Very Low Birth Weight Preterm Infants
by Dr. Khalid N Haque


Over the last fifty years neonatal care has made tremendous progress; increasing survival, reducing morbidity, developing newer modalities of care and therapy for the very low birth weight (VLBW) and ...read more >
Latest Articles & Publications
by Shyam

1. A Word in the Transitions : Managig the transfer pricing implications of complex supply chains.

2. Pressure to act now - New US Rules for Resolutions Plans

3. Yuvodoo - Booer Video - Road to Durbanread more >

MULTIMEDIA



Heart Rate And Qt Interval In Streptozotocin-induced Diabetic Rat
by Mr. Chris Howarth

Prolonged QT interval is a common finding in diabetic patients. The effects of streptozotocin (STZ) induced diabetes on QT interval has been investigated by application of 4 standard QT correction algorithms. The electrocardiogram was recorded in STZ-treated (60 mg/kg bodyweight, ip) and age-matched control rats with a biotelemetry system for the period of the study. Heart rate (HR) was significantly (P < 0.01) reduced and QT interval was signifycantly (P < 0.05) prolonged in diabetic rats compared to controls at 8, 10 and 12 weeks after STZ treatment.
read more >
Modulation Of Serine Proteases-mediated Platelet Activation By Novel Direct Thrombin Inhibitors
by Dr. Sarfraz Ahmad


Novel direct thrombin inhibitors (DTIs), such as bivalirudin, are replacing heparin in several clinical scenarios. In particular, DTIs are indicated for the treatment and thromboprophylaxis of patient...read more >
add3

NEWS

read more news >

BLOG

read more >
strober
jms Home Current Issues Browse Archieve Editorial Board Best Submissions Video & Multimedia Blog Subscribe Faq
Subsribe HMJ Journals Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2010 - 2011 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA